scispace - formally typeset
M

Meixia Ren

Researcher at Fujian Medical University

Publications -  21
Citations -  1752

Meixia Ren is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Genome-wide association study & Blood pressure. The author has an hindex of 11, co-authored 18 publications receiving 1173 citations. Previous affiliations of Meixia Ren include National Institute for Health Research & Queen Mary University of London.

Papers
More filters
Journal ArticleDOI

Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.

Evangelos Evangelou, +341 more
- 17 Sep 2018 - 
TL;DR: In this article, the largest genetic association study of blood pressure traits (systolic, diastolic and pulse pressure) to date in over 1 million people of European ancestry was conducted.
Journal ArticleDOI

Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk

Helen R. Warren, +74 more
- 01 Mar 2017 - 
TL;DR: In this paper, the authors report genetic association of blood pressure (systolic, diastolic, pulse pressure) among UK Biobank participants of European ancestry with independent replication in other cohorts, and robust validation of 107 independent loci.

Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk

Helen R. Warren, +267 more
TL;DR: Results from genetic risk score models raise the possibility of a precision medicine approach through early lifestyle intervention to offset the impact of blood pressure–raising genetic variants on future cardiovascular disease risk.
Journal ArticleDOI

Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney

Louise V. Wain, +270 more
- 24 Jul 2017 - 
TL;DR: 48 genes with evidence for involvement in blood pressure regulation that are significant in multiple resources are identified and these robustly implicated genes may provide new leads for therapeutic innovation.